2016
DOI: 10.1155/2016/2145753
|View full text |Cite
|
Sign up to set email alerts
|

Anti-Inflammatory Effects of Protein Kinase Inhibitor Pyrrol Derivate

Abstract: In our previous studies we showed antitumor and anti-inflammatory activities of protein kinases inhibitor pyrrol derivate 1-(4-Cl-benzyl)-3-Cl-4-(CF3-fenylamino)-1H-pyrrol-2,5-dione (MI-1) on rat colon cancer model. Therefore anti-inflammatory effect of MI-1 on rat acetic acid induced ulcerative colitis (UC) model was aimed to be discovered. The anti-inflammatory effects of MI-1 (2.7 mg/kg daily) compared to reference drug Prednisolone (0.7 mg/kg daily) after 14-day usage were evaluated on macro- and light mic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
11
0
4

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 34 publications
1
11
0
4
Order By: Relevance
“…However, it affects the cell redox state because of a close relationship with numerous other signalings. For example, growth factor receptor inhibitors have been shown to release anti-inflammatory and anti-fibrotic activity also exhibit antioxidant one [ 69 , 70 ]. Although there are no proven anti-fibrotic therapeutics, numerous studies are underway to identify new ones and to establish anti-fibrotic activity for popular treatments of liver diseases accompanied by its fibrous degeneration [ 71 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, it affects the cell redox state because of a close relationship with numerous other signalings. For example, growth factor receptor inhibitors have been shown to release anti-inflammatory and anti-fibrotic activity also exhibit antioxidant one [ 69 , 70 ]. Although there are no proven anti-fibrotic therapeutics, numerous studies are underway to identify new ones and to establish anti-fibrotic activity for popular treatments of liver diseases accompanied by its fibrous degeneration [ 71 ].…”
Section: Discussionmentioning
confidence: 99%
“…1) [2]. Ýòî ñîåäèíåíèå îáëàäàåò ïðîòèâîîïóõîëåâîé àêòèâ-íîñòüþ, ñðàâíèìîé ñ òàêîâîé êëàññè÷åñêîãî ïðåïàðàòà 5-ôòîð-óðàöèëà [12].…”
Section: ââåäåíèåunclassified
“…Âëèÿíèå Ä1 íà îðãàíû ïèùåâàðåíèÿ êðûñ èññëåäîâàëè ïðè ââå-äåíèè äàííîãî ñîåäèíåíèÿ â äîçå 2,3 ìã/êã (÷òî ïðè óñ-ëîâèè ïîëíîãî âñàñûâàíèÿ ïðåäïîëàãàåò êîíöåíòðàöèþ â êðîâè 10 -4 Ì), ðàñòâîðåííîãî â ðàñòèòåëüíîì ìàñëå, ñîäåðaeàùåãî 15 % ÄÌÑÎ (âñåãî 0,1 ìë), ïåðîðàëüíî åaeåäíåâíî â òå÷åíèå 7 è 27 íåäåëü. Îïóõîëè òîëñòîãî êèøå÷íèêà èíäóöèðîâàëè ñîãëàñíî [12,14]. 1,2-Äèìå-òèëãèäðàçèí (ÄÌÃ) (Acros Organics, USA) (20 ìã/êã â 0,1 ìë ôèçèîëîãè÷åñêîãî ðàñòâîðà) ââîäèëè ïîäêîaeíî åaeåíåäåëüíî â òå÷åíèå ïåðâûõ 20 íåäåëü ýêñïåðèìåíòà, ÷òî ÿâëÿåòñÿ äîñòàòî÷íûì äëÿ íåîáðàòèìîé èíäóêöèè ðàçâèòèÿ îïóõîëåé òîëñòîãî êèøå÷íèêà ïðàêòè÷åñêè â 100 % ñëó÷àåâ.…”
Section: ìåòîäû èññëåäîâàíèßunclassified
See 2 more Smart Citations